Primary information |
---|
CancerPDF_ID | CancerPDF_ID12858 |
PMID | 23915341 |
Peptide Sequence | NA |
Peptide Sequence in Publication | NA |
Protein Name | NA |
UniprotKB Entry Name | NA |
Biofluid | Serum |
M/Z | NA |
Charge | NA |
Mass/H+ | NA |
Mass (in Daltons) | 2168.67 |
Profiling Technique | MALDI-TOF |
Peptide Identification Technique | LC/ESI MS-MS |
Quantification Technique | NA |
Labeling | Label Free |
FDR | NA |
p-Value | 5.73E-05 |
Software | Bioworks Browser |
Length of Peptide | NA |
Cancer Type | Acute myeloid leukemia (AML) |
Database for Peptide search | IPI Human Database ( v3.45 ) |
Modification | NA |
Number of Patients | "72 healthy controls were selected from adult healthy examinees without any diseases. In addition, 37 serum samples were obtained from AML patients with hematologic CR and 30 serum samples from refractory & relapsed AML patients." |
Regulation/Differential Expression | Downregulated in AML vs healthy |
Validation | NA |
Sensitivity | NA |
Specificity | NA |
Accuracy | NA |
Secondary information |
---|
Peptide Atlas | NA |
IEDB | |